Anyone keeping score at home will probably know that Abbott’s new Similac baby formula recall isn’t the company’s first recall this year. We saw a massive recall action in mid-February ...
Abbott Laboratories and a unit of Reckitt Benckiser Group were cleared by a jury over claims they hid risks in their premature-infant formulas can cause a bowel disease that severely sickened a baby ...
The decision marks the first victory for the companies as they face more than 1,000 similar cases and previously lost trials, one of which ended with a $500 million verdict.
A jury found Abbott Laboratories and Mead Johnson, owned by U.K.-based Reckitt Benckiser, not responsible for a young boy's intestinal disease, the result of a lawsuit that alleged the companies ...
We apologize, but this video has failed to load. Premature infant formulas Similac Neosure and EnfaCare, which come from two U.S. companies, have been out of stock since at least the beginning of the ...
The US Department of Justice is investigating Abbott Laboratories, the maker of Similac baby formula, over its conduct that resulted in a plant shutdown and nationwide shortages last year.